XORTX Therapeutics XRTX Growth Metrics (2020-2026)

NASDAQ XRTX
$1.69 -0.01 (-0.55%)
As of: Sep 30, 2026 · 9:54 AM EDT
Reported Financials

XORTX Therapeutics Quarterly Growth Metrics

Periods 25 quarters
Latest Jun 2026

XORTX Therapeutics reported asset growth of 125.53% for the quarter ended Jun 2026. These growth metrics cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
895.04%84.35%-29.40%-33.66%-38.01%-42.11%-55.70%-37.36%-38.48%-42.01%-25.12%-42.18%-42.87%-26.99%-34.46%-38.70%125.53%
Assets Growth (3y)
46.00%-14.79%-38.36%-37.83%-39.83%-37.42%-39.87%-39.44%-7.45%
Assets Growth (5y)
8.84%
Assets (QoQ)
180.95%-16.72%-13.56%-8.85%7.59%-21.74%-19.23%-14.88%-17.65%10.66%-20.68%-19.77%6.34%-14.55%-21.63%2.52%-4.54%-20.08%188.34%
Capital Expenditures Growth (1y)Capex Growth (1y)
99.98%
Capital Expenditures (QoQ)Capex (QoQ)
-929.90%41.64%38.76%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
11,283.80%134.84%-30.42%-35.41%-41.44%-45.63%-66.87%-51.50%-50.06%-54.61%-28.25%-50.59%-65.45%-48.11%-65.05%-86.79%-6.53%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
197.17%-16.63%-45.11%-46.31%-53.43%-49.60%-56.37%-68.37%-45.57%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
45.76%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
276.70%-18.13%-14.03%-11.43%11.61%-24.00%-22.06%-17.76%-31.99%11.25%-19.74%-25.26%7.52%-23.38%-43.89%12.27%-27.59%-71.05%297.18%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-186.72%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-299.63%
EBIT Growth (1y)
-1,738.39%1,672.23%-249.79%-571.38%82.06%-128.35%34.20%-29.62%-5.24%222.15%-59.51%113.50%40.98%-93.82%68.81%-522.01%-20.78%-4,852.54%-17.60%-135.19%
EBIT Growth (3y)
-51.41%95.26%-54.27%46.98%51.88%-72.24%31.08%9.61%9.14%-53.09%16.37%-10.25%
EBIT Growth (5y)
-19.86%-74.09%-6.13%-63.44%
EBIT (QoQ)
-3,539.77%208.69%-137.28%54.48%2.73%-71.74%13.47%10.33%21.03%299.34%-213.00%107.59%-445.17%120.87%-670.18%-2.72%1.21%-721.38%85.89%-105.43%
EBT Growth (1y)
-12.25%-249.68%-372.26%-277.06%-185.39%-24.08%52.86%52.56%-51.79%227.51%19.67%-18.59%37.22%-132.75%11.50%40.42%18.13%-781.26%14.55%-89.97%
EBT Growth (3y)
-69.42%96.02%-21.38%-28.49%-39.59%19.68%30.54%30.53%7.94%-54.39%15.31%-10.31%
EBT Growth (5y)
-20.11%-74.04%-6.22%-19.15%
EBT (QoQ)
54.32%-296.81%-125.25%7.65%65.42%-72.52%14.43%7.06%-10.62%244.93%-153.91%-37.21%41.44%24.41%-45.70%7.63%19.52%-713.67%85.87%-105.35%
EPS (Basic) Growth (1y)
-1,573.99%-290.77%-6.50%-372.31%87.78%8.26%62.93%24.92%41.55%195.22%-22.17%110.08%53.72%-122.55%78.30%-390.54%23.83%154.29%29.65%-43.22%
EPS (Basic) Growth (3y)
-154.11%-10.69%-6.13%18.56%21.57%33.09%67.91%41.82%53.85%39.64%40.93%28.39%42.87%25.14%
EPS (Basic) Growth (5y)
-34.18%16.86%15.87%-27.24%40.65%-8.27%
EPS (Basic) (QoQ)
-3,634.69%86.99%-111.75%54.11%3.41%2.27%14.43%7.06%24.80%259.21%-209.79%107.67%-445.17%22.45%-5.66%-2.72%9.51%155.27%-236.92%-109.13%
EPS (Diluted) Growth (1y)
-290.77%-6.50%-372.31%87.78%8.26%62.93%24.92%41.55%195.22%-22.17%110.08%53.72%-122.55%78.30%-390.54%23.83%154.29%29.65%-43.22%
EPS (Diluted) Growth (3y)
18.56%21.57%33.09%67.91%41.82%53.85%39.64%40.93%28.39%42.87%25.14%
EPS (Diluted) Growth (5y)
-27.24%40.65%-8.27%
EPS (Diluted) (QoQ)
-3,634.69%86.99%-111.75%54.11%3.41%2.27%14.43%7.06%24.80%259.21%-209.79%107.67%-445.17%22.45%-5.66%-2.72%9.51%155.27%-236.92%-109.13%
Free Cash Flow Growth (1y)FCF Growth (1y)
100.00%
Free Cash Flow (QoQ)FCF (QoQ)
-299.34%100.07%-38.76%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
867.75%-55.08%51.61%99.42%-101.20%-60.05%78.09%39.70%232.10%90.62%120.50%3.50%-91.07%60.30%-1,330.91%-386.80%-30,795.19%-1,225.00%-979.29%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
28.49%38.48%26.45%85.04%-88.79%60.94%17.92%-41.49%-230.80%20.98%-200.85%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-27.15%-4.14%-23.62%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-2,677.44%156.75%-118.55%83.45%66.99%-18.00%-2,383.21%97.73%9.18%358.51%-276.30%104.95%-527.57%123.92%-884.07%-53.52%-69.09%-1,408.09%66.15%-25.05%
Net Cash Flow (QoQ)NCF (QoQ)
196.70%
Net Income Growth (1y)
-2,216.23%2,177.60%-57.38%-597.94%81.95%-129.80%32.21%-1.55%20.94%193.93%-64.79%113.50%38.02%-93.93%76.86%-522.01%-10.64%-581.87%-15.72%-135.58%
Net Income Growth (3y)
-280.60%-49.93%-48.96%98.44%-20.69%43.53%55.45%-74.30%36.30%16.67%18.46%35.00%23.87%-10.31%
Net Income Growth (5y)
-83.88%-13.94%-17.78%-11.20%13.99%-56.92%
Net Income (QoQ)
-3,634.69%208.71%-137.46%54.11%3.41%-79.45%14.78%31.25%24.80%313.19%-249.51%105.63%-445.17%120.87%-670.18%-2.72%9.51%9.09%-36.92%-109.13%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-1,981.46%-381.91%-57.38%-597.94%81.95%-24.08%49.86%-1.55%20.94%227.51%-63.59%113.50%38.02%-132.75%68.48%-522.01%-10.64%189.29%-15.72%-135.58%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-244.20%-49.93%-43.75%64.61%-8.89%43.53%55.45%19.68%36.30%16.67%18.46%33.38%15.82%-10.31%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-83.88%-13.94%-15.29%5.46%13.99%-56.92%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-3,634.69%80.77%-111.75%54.11%3.41%-32.18%14.43%7.06%24.80%313.19%-209.79%107.67%-445.17%-12.65%-5.66%-2.72%9.51%190.91%-236.92%-109.13%
Operating Income Growth (1y)Op. Inc Growth (1y)
-571.38%-29.62%113.50%40.98%-93.82%68.81%-522.01%
Operating Income Growth (3y)Op. Inc Growth (3y)
46.98%51.88%-72.24%31.08%9.61%
Operating Income (QoQ)Op. Inc (QoQ)
-3,539.77%208.69%-137.28%54.48%21.03%299.34%-213.00%107.59%-445.17%120.87%-670.18%-2.72%
Profit After Tax Growth (1y)PAT Growth (1y)
-12.25%-249.68%-372.26%-277.06%-185.39%-24.08%52.86%52.56%-3.18%227.51%-63.59%-18.59%7.64%-132.75%56.54%40.42%18.13%-781.26%14.55%-89.97%
Profit After Tax Growth (3y)PAT Growth (3y)
-48.96%96.02%-53.85%-28.49%-39.59%19.68%30.54%30.53%7.94%-54.39%15.31%-10.31%
Profit After Tax Growth (5y)PAT Growth (5y)
-20.11%-74.04%-6.22%-19.15%
Profit After Tax (QoQ)PAT (QoQ)
54.32%-296.81%-125.25%7.65%65.42%-72.52%14.43%7.06%24.80%313.19%-209.79%32.62%41.44%24.41%-45.70%7.63%19.52%-713.67%85.87%-105.35%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
47.24%21.86%28.44%45.11%-31.13%11.78%9.90%6.75%-3.78%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
31.63%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-30.27%-43.33%-7.41%233.11%-26.51%-35.98%-56.06%440.67%-27.75%-37.81%-60.39%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-5770.00-4583.00-3111.00-3645.003,128.001,916.005,854.008,212.00-4332.00-539.00-8354.00-4631.006,786.0010,934.0011,721.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-6973.00-3207.00-5611.00-64.005,583.0012,310.009,221.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-882.00-2323.00-1402.00-1162.00304.00-851.00-1937.005,611.00-908.003,087.00422.00-6933.002,884.00-4727.004,145.004,485.007,032.00-3940.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-5195.00-3241.00-3783.00-9832.002,252.00118.003,034.005,336.00-4680.001,368.00-4558.00-7742.00-29116.00-48703.00-18138.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-7623.00-1755.00-5307.00-12238.00-31544.00-47216.00-19662.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-1250.00-988.004,411.00-7368.00704.00-1530.00-1639.004,717.00-1430.001,386.00663.00-5299.004,618.00-4540.00-2521.00-26674.00-14968.0026,024.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-10207.00-6375.00-1809.00-2044.006,967.001,271.003,633.007,300.00-7809.001,371.00-8967.00-5586.0010,076.0014,544.0015,260.00
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-11049.00-3733.00-7143.00-331.009,235.0017,186.009,926.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-1882.00-3130.00-1923.00-3272.001,950.001,436.00-2158.005,739.00-3746.003,798.001,509.00-9370.005,435.00-6541.004,890.006,293.009,902.00-5825.00
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
2,099.36%-57.57%352.97%-60.99%-37.72%-41.88%-90.77%13.32%-59.36%34.35%43.10%-27.43%-67.01%-83.12%-84.23%-67.73%-56.61%-12.86%-69.29%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
77.23%-30.81%-15.73%-31.54%-56.29%-49.11%-72.48%-35.74%-61.26%-41.75%-58.92%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
-4.44%-45.35%-50.75%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-32.83%130.31%-40.22%389.81%-94.22%267.74%-44.22%-22.20%-28.99%31.88%84.40%-17.13%-63.99%-40.06%-5.64%-22.57%-26.32%-19.41%89.52%-72.71%
Total Debt (QoQ)
-0.33%-2.06%-6.69%

XORTX Therapeutics Growth Metrics API

Pull XORTX Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XRTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY